Float Short %

0.44

Margin Of Safety %

Put/Call OI Ratio

0.86059837490019

EPS Next Q Diff

5.04

EPS Last/This Y

EPS This/Next Y

4.84

Price

62.08

Target Price

107.74

Analyst Recom

2.03

Performance Q

-29.43

Relative Volume

0.9

Beta

0.67

Ticker: NVO

22 items of 1

Date	Symbol	Last	P/C OI	P/C Vol	Total OI
2025-03-27	NVO	70.17	0.89	2.32	464962
2025-03-28	NVO	69.28	0.92	1.63	490616
2025-03-31	NVO	69.47	0.94	0.83	465169
2025-04-01	NVO	68.06	0.88	0.76	462879
2025-04-02	NVO	68.33	0.86	0.66	470700
2025-04-03	NVO	67.12	0.86	1.40	477035
2025-04-04	NVO	62.54	0.85	1.46	475949
2025-04-07	NVO	63.66	0.78	0.59	447293
2025-04-08	NVO	61.5	0.76	0.60	460459
2025-04-09	NVO	65.08	0.75	1.69	477126
2025-04-10	NVO	61.2	0.76	1.33	502808
2025-04-11	NVO	64.75	0.77	0.81	520265
2025-04-14	NVO	66.04	0.79	1.15	504695
2025-04-15	NVO	64.49	0.80	1.63	510389
2025-04-16	NVO	62.89	0.82	2.96	523116
2025-04-17	NVO	58.01	0.80	0.98	524741
2025-04-18	NVO	58.08	0.80	0.98	524741
2025-04-21	NVO	58.29	0.90	0.58	480016
2025-04-22	NVO	59.89	0.89	0.58	493668
2025-04-23	NVO	61.29	0.88	0.52	497131
2025-04-24	NVO	62.57	0.87	1.54	503280
2025-04-25	NVO	62.08	0.86059837490019	1.3808470549685	514982
Date	Symbol	Last	P/C OI	P/C Vol	Total OI

22 items 1 of 1

22 items of 1

Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year
2025-03-27	NVO	70.14	10.3	4736.1	27.20
2025-03-28	NVO	69.30	10.3	5018.5	27.20
2025-03-31	NVO	69.44	10.2	6637.3	27.22
2025-04-01	NVO	68.03	8.1	6366.6	26.88
2025-04-02	NVO	68.24	8.1	5989.0	26.88
2025-04-03	NVO	67.10	8.1	6186.2	26.88
2025-04-04	NVO	62.54	7.2	4188.0	26.71
2025-04-07	NVO	63.64	7.2	5863.7	26.71
2025-04-08	NVO	61.60	7.2	4987.1	26.71
2025-04-09	NVO	65.09	7.2	6276.7	26.71
2025-04-10	NVO	61.21	7.2	6526.5	26.71
2025-04-11	NVO	64.74	7.2	7574.7	26.71
2025-04-14	NVO	66.06	7.2	5504.9	26.71
2025-04-15	NVO	64.49	7.2	4139.8	26.71
2025-04-16	NVO	62.90	7.2	4113.0	26.71
2025-04-17	NVO	58.08	7.2	2415.9	26.71
2025-04-18	NVO	58.08	7.2	2415.9	26.73
2025-04-21	NVO	58.30	6.9	2492.3	26.73
2025-04-22	NVO	59.91	6.9	6995.2	26.73
2025-04-23	NVO	61.30	6.9	9585.9	26.73
2025-04-24	NVO	62.59	6.9	8878.4	26.73
2025-04-25	NVO	62.08	6.9	8585.1	26.73
Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year

22 items 1 of 1

22 items of 1

Date	Ticker	Insider Transactions	Institutional Transactions	Float Short
2025-03-27	NVO	0.00	0.32	0.38
2025-03-28	NVO	0.00	0.32	0.38
2025-03-31	NVO	0.00	-0.91	0.38
2025-04-01	NVO	0.00	-0.91	0.38
2025-04-02	NVO	0.00	-0.91	0.38
2025-04-03	NVO	0.00	-0.91	0.38
2025-04-04	NVO	0.00	-0.91	0.38
2025-04-07	NVO	0.00	0.02	0.38
2025-04-08	NVO	0.00	0.02	0.38
2025-04-09	NVO	0.00	0.02	0.38
2025-04-10	NVO	0.00	0.02	0.44
2025-04-11	NVO	0.00	0.02	0.44
2025-04-14	NVO	0.00	0.19	0.44
2025-04-15	NVO	0.00	0.19	0.44
2025-04-16	NVO	0.00	0.19	0.44
2025-04-17	NVO	0.00	0.19	0.44
2025-04-18	NVO	0.00	0.19	0.44
2025-04-21	NVO	0.00	0.16	0.44
2025-04-22	NVO	0.00	0.16	0.44
2025-04-23	NVO	0.00	0.16	0.44
2025-04-24	NVO	0.00	0.16	0.44
2025-04-25	NVO	0.00	0.16	0.44
Date	Ticker	Insider Transactions	Institutional Transactions	Float Short

22 items 1 of 1

Last Quarter Act. EPS

0.91

Avg. EPS Est. Current Quarter

6.14

Avg. EPS Est. Next Quarter

5.95

Insider Transactions

Institutional Transactions

0.16

Beta

0.67

Average Sales Estimate Current Quarter

79034

Average Sales Estimate Next Quarter

79863

Fair Value

82.08

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

58.1

Max Drawdown 5-Year %

-59.7

Target Price

107.74

P/E

18.91

Forward P/E

12.94

PEG

0.96

P/S

4.96

P/B

13.84

P/Free Cash Flow

19.51

EPS

3.28

Average EPS Est. Cur. Y

26.73

EPS Next Y. (Est.)

31.56

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

34.81

Relative Volume

0.9

Return on Equity vs Sector %

49.2

Return on Equity vs Industry %

41.1

EPS 1 7Days Diff

26.7

EPS 1 30Days Diff

26.73

EBIT Estimation

8585.1

Novo Nordisk A/S

Sector: Healthcare

Industry: Drug Manufacturers - General

Employees: 76302

Novo Nordisk A/S, together with its subsidiaries, engages in the research and development, manufacture, and distribution of pharmaceutical products in Europe, the Middle East, Africa, Mainland China, Hong Kong, Taiwan, North America, and internationally. It operates in two segments, Diabetes and Obesity Care, and Rare Disease. The Diabetes and Obesity care segment provides products for diabetes, obesity, cardiovascular, and other emerging therapy areas. The Rare Disease segment offers products in the areas of rare blood disorders, rare endocrine disorders, and hormone replacement therapy. The company also provides insulin pens, growth hormone pens, and injection needles. In addition, it offers smart solutions for diabetes treatment, such as smart insulin pens and Dose Check, an insulin dose guidance application. The company has a collaboration agreement with UNICEF to tackle childhood obesity; and with Valo Health, Inc. to discover and develop novel drug programmes for cardiometabolic space. Novo Nordisk A/S was founded in 1923 and is headquartered in Bagsvaerd, Denmark.

stock quote shares NVO – Novo Nordisk A/S Stock Price stock today

news today NVO – Novo Nordisk A/S stock forecast ,stock prediction 2023 2024 2025

marketwatch NVO – Novo Nordisk A/S yahoo finance google finance

stock history NVO – Novo Nordisk A/S invest stock market

stock prices NVO premarket after hours

ticker NVO fair value insiders trading

Investment involves risk. As a general rule, you should only trade in financial products that you are familiar with and understand the risk associated with them. The risk warning described in each financial product below is not exhaustive, you should carefully consider your investment experience, financial situation, investment objective, risk tolerance level and consult your independent financial adviser as to the suitability of your situation prior making any investment.

Float Short %

Margin Of Safety %

Put/Call OI Ratio

EPS Next Q Diff

EPS Last/This Y

EPS This/Next Y

Price

Target Price

Analyst Recom

Performance Q

Relative Volume

Beta

Ticker: NVO

Last Quarter Act. EPS​

Avg. EPS Est. Current Quarter

Avg. EPS Est. Next Quarter

Insider Transactions

Institutional Transactions

Beta

Average Sales Estimate Current Quarter

Average Sales Estimate Next Quarter

Fair Value

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

Max Drawdown 5-Year %

Target Price

P/E

Forward P/E

PEG

P/S

P/B

P/Free Cash Flow

EPS

Average EPS Est. Cur. Y​

EPS Next Y. (Est.)

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

Relative Volume

Return on Equity vs Sector %

Return on Equity vs Industry %

EPS 1 7Days Diff

EPS 1 30Days Diff

EBIT Estimation

Get Started

About

Last Quarter Act. EPS

Average EPS Est. Cur. Y